News

Eli Lilly and Company thrives on its groundbreaking weight-loss drug tirzepatide. Learn why we could see a $50B market and ...
Mounjaro (tirzepatide), a weight-loss injection, is now approved to treat moderate-to-severe obstructive sleep apnea in obese ...